BioCentury
ARTICLE | Clinical News

L-DOS47: Interim Phase I/II data

September 14, 2015 7:00 AM UTC

Interim data from 40 patients with inoperable, locally advanced, recurrent or metastatic non-squamous stage IIIb/IV NSCLC in the first 12 dosing cohorts of the open-label, Polish Phase I/II LDOS002 tr...